CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
Stanford University
Stanford University
Dana-Farber Cancer Institute
The First Affiliated Hospital with Nanjing Medical University
Virginia Commonwealth University
Ruijin Hospital
Masonic Cancer Center, University of Minnesota
Stichting Hemato-Oncologie voor Volwassenen Nederland
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
The First Affiliated Hospital of Soochow University
Sun Yat-sen University
University of Arizona
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of Nebraska
Insel Gruppe AG, University Hospital Bern
The Lymphoma Academic Research Organisation
Medical University of Vienna
Florida International University
Ain Shams University
Masonic Cancer Center, University of Minnesota
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota